Skip to main content

Displaying 81 - 100 of 419

AbbVie Inc. and Allergan plc, In the Matter of

Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent agreement in this matter.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0169
Case Status
Pending

Evonik/PeroxyChem, In the Matter of

The Federal Trade Commission authorized an action to block Evonik Industries AG’s proposed $625 million acquisition of PeroxyChem Holding Company, alleging the merger of the chemical companies would substantially reduce competition in the Pacific Northwest and the Southern and Central United States for the production and sale of hydrogen peroxide, a commodity chemical used for oxidation, disinfection, and bleaching.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0029
Docket Number
9384
Case Status
Closed